Digestive Care, Inc.

BEN FRANKLIN TECHNOLOGY CENTER, 115 RESEARCH DR
Bethlehem, NJ 18015

SBIR Award Summary

Total Number of Awards 15
Total Value of Awards $149K
First Award Date 05/15/91
Most Recent Award Date 05/01/01

Key Personnel

Last Name Name Awards Contact
Sipos Tibor Sipos 15

15 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/01 - 10/31/01

DESCRIPTION (provided by applicant): The overall objective of this project is to establish the scientific rationale for the exogenous administration of a bicarbonate-buffered and enteric-coated pancrelipase to human immunodeficiency virus (HIV) positive patients who experience diarrhea due to High Activity Antiret...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/98 - 03/31/99

ESCRIPTION: (Adapted from the applicant's abstract) The overall objective of this program is to commercially develop a novel Intraoral Salivary Flow Stimulant (ISFS) releasing system for radiation- induced xerostomia patients which is superior to the currently marketed orally administered pro...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/98 - 02/28/99

DESCRIPTION (Adapted from the application): The overall objectives of this proposal are to (1) prepare a 25 kg batch of a buffered pancrelipase composition under good manufacturing practices (GMP) conditions for clinical supplies and (2) demonstrate the clinical efficacy of a buffered pancrelipase compositio...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/97 - 09/29/98

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/96 - 03/31/97

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/95 - 08/31/96

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/95 - 03/31/97

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/15/95 - 10/14/95

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/94 - 06/30/95

The overall objective of this program is to commercially develop an innovative Intraoral Fluoride Releasing System (IFRS) for high-caries-risk patients which is superior to the currently marketed oral care products in that it does not depend on patient compliance for efficacy in preventing the development of dental caries. The broad objectives ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/93 - 08/31/94

The overall objective of this program is to commercially develop a significantly improved high potency dosage form of a novel digestive adjuvant. The target pharmaceutical is a stable polymer-coated (p.c.) digestive enzyme/bile acid-containing microsphere (DIGESTIZYME) for pancreatic enzyme-deficient cystic fibrosis (C.F.) patients that is supe...

Load More